Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals

Infection Control and Hospital Epidemiology

Volumn 32, Issue 7, 2011, Pages 649-655

  Zilberberg, Marya D ^a   Tabak, Ying P ^b   Sievert, Dawn M ^c   Derby, Karen G ^b   Johannes, Richard S ^b,d   Sun, Xiaowu ^b   Clifford McDonald, L ^c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b MedMined Services   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN; ENDOTOXIN;

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; PATIENT CARE; POISSON DISTRIBUTION; PREVALENCE; RISK; UNITED STATES;

ADULT; AGED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE NOTIFICATION; ELECTRONIC HEALTH RECORDS; HOSPITALS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; POPULATION SURVEILLANCE; RISK FACTORS; UNITED STATES;

EID: 79958761012     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660360     Document Type: Article

References (23)

1. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366(9491):1079-1084.
2. Stabler RA, Dawson LF, Phua LTH, Wren BW. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J Med Microbiol 2008; 57(6):771-775.
3. Wilcox MH, Fawley WN. Hospital disinfectants and spore formation by Clostridium difficile. Lancet 2000;356(9238):1324.
4. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008;14(6):929-931.
5. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010;16(4):604-609.
6. Norén T, Åkerlund T, Bäck E, et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 2004;42(8): 3635-3643.
7. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28(2):140-145.
8. Association for Professionals in Infection Control and Epidemiology (APIC). Legislation in progress. http://www.apic.org/map/index.htm. Accessed September 16, 2010.
9. Benoit S, McDonald L, English R, Tokars J. Automated surveillance of Clostridium difficile infections using BioSense. Infect Control Hosp Epidemiol 2011;32(1):26-33.
10. Brossette SE, Hacek DM, Gavin PJ, et al. A laboratory-based, hospital-wide, electronic marker for nosocomial infection: the future of infection control surveillance? Am J Clin Pathol 2006; 125(1):34-39.
11. Brossette SE, Sprague AP, Hardin JM, Waites KB, Jones WT, Moser SA. Association rules and data mining in hospital infection control and public health surveillance. J Am Med Inform Assoc 1998;5(4):373-381.
12. Kilgore ML, Ghosh K, Beavers CM, Wong DY, Hymel PA Jr, Brossette SE. The costs of nosocomial infections. Med Care 2008; 46(1):101-104.
13. American Hospital Association (AHA). Annual Survey Database, Chicago, Ill. Fiscal Year 2007. http://www.aha.org/. Accessed September 16, 2010.
14. Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann Intern Med 2009;151(3):176-179.
15. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009;37(4):263-270.
16. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
17. Luo RF, Banaei N. Is repeat PCR needed for the diagnosis of Clostridium difficile infection? J Clin Microbiol 2010;48(10): 3738-3741.
18. Campbell RJ, Giljahn L, Machesky K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009;30(6):526-533.
19. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010;31(10):1030-1037.
20. Agency for Healthcare Research and Quality (AHRQ). Healthcare Cost and Utilization Project (HCUP). http://www.ahrq.gov/data/hcup/. Accessed September 16, 2010.
21. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010;31(3):262-268.
22. Centers for Disease Control and Prevention. Multidrug-Resistant Organism and Clostridium difficile-Associated Disease (MDRO/CDAD) Module. http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf. Accessed September 16, 2010.
23. Centers for Disease Control and Prevention. National Healthcare Safety Network (NHSN): clinical document architecture (CDA). http://www.cdc.gov/nhsn/CDA_eSurveillance.html. Accessed September 16, 2010.